These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 10638597)
21. Tamoxifen induced-non-alcoholic steatohepatitis (NASH): has the time come for the oncologist to be diabetologist. Ahmed MH; Osman KA Breast Cancer Res Treat; 2006 May; 97(2):223-4. PubMed ID: 16322887 [No Abstract] [Full Text] [Related]
22. Fatty liver and transaminase changes with adjuvant tamoxifen therapy. Liu CL; Huang JK; Cheng SP; Chang YC; Lee JJ; Liu TP Anticancer Drugs; 2006 Jul; 17(6):709-13. PubMed ID: 16917217 [TBL] [Abstract][Full Text] [Related]
23. Tamoxifen in liver disease: potential exacerbation of hepatic dysfunction. Floren LC; Hebert MF; Venook AP; Jordan VC; Cisneros A; Somberg KA Ann Oncol; 1998 Oct; 9(10):1123-6. PubMed ID: 9834826 [TBL] [Abstract][Full Text] [Related]
24. [Thrombophlebitis in an Elderly Japanese Woman Treated with Tamoxifen for Breast Cancer]. Takayanagi H; Hayami R; Tsuneizumi M; Nakagami K Gan To Kagaku Ryoho; 2015 Oct; 42(10):1203-5. PubMed ID: 26489549 [TBL] [Abstract][Full Text] [Related]
25. Size and oxidative susceptibility of low-density lipoprotein particles in breast cancer patients with tamoxifen-induced fatty liver. Wakatsuki A; Ogawa Y; Saibara T; Okatani Y; Fukaya T J Clin Endocrinol Metab; 2002 Aug; 87(8):3676-81. PubMed ID: 12161495 [TBL] [Abstract][Full Text] [Related]
26. [Viral Hepatitis A over imposed on chronic hepatic damage due to tamoxifen: report of a case]. Vildozola H; Vargas G; Takano J Rev Gastroenterol Peru; 2007; 27(1):67-71. PubMed ID: 17431437 [TBL] [Abstract][Full Text] [Related]
27. Tamoxifen-induced submassive hepatic necrosis. Storen EC; Hay JE; Kaur J; Zahasky K; Hartmann L Cancer J; 2000; 6(2):58-60. PubMed ID: 11069218 [No Abstract] [Full Text] [Related]
28. Tamoxifen and depression: drug interactions in breast cancer. McMichael KS; Adams K; Breden Crouse EL Consult Pharm; 2013 Sep; 28(9):584-91. PubMed ID: 24007891 [TBL] [Abstract][Full Text] [Related]
29. An unusual cause of jaundice in a patient with breast cancer. Lacey R; Evans A BMJ Case Rep; 2014 Dec; 2014():. PubMed ID: 25540208 [TBL] [Abstract][Full Text] [Related]
32. Fatty liver and drugs. Grieco A; Forgione A; Miele L; Vero V; Greco AV; Gasbarrini A; Gasbarrini G Eur Rev Med Pharmacol Sci; 2005; 9(5):261-3. PubMed ID: 16237810 [TBL] [Abstract][Full Text] [Related]
33. Relationships between tamoxifen use, liver fat and body fat distribution in women with breast cancer. Nguyen MC; Stewart RB; Banerji MA; Gordon DH; Kral JG Int J Obes Relat Metab Disord; 2001 Feb; 25(2):296-8. PubMed ID: 11410835 [TBL] [Abstract][Full Text] [Related]
35. Detection of endometrial cancer in asymptomatic postmenopausal breast cancer patient treated with tamoxifen: a case report. Sinawat S; Chiyabutra T; Kleabkaew P J Med Assoc Thai; 2001 Jul; 84(7):1033-6. PubMed ID: 11759963 [TBL] [Abstract][Full Text] [Related]
36. The association between tamoxifen and the development of hepatocellular carcinoma: case report and literature review. Law CH; Tandan VR Can J Surg; 1999 Jun; 42(3):211-4. PubMed ID: 10372018 [TBL] [Abstract][Full Text] [Related]
38. Drug-induced liver injury secondary to tamoxifen. Subhaharan D; Murphy G; Commins N; Azer M BMJ Case Rep; 2024 Jun; 17(6):. PubMed ID: 38839414 [TBL] [Abstract][Full Text] [Related]
39. Adjuvant treatment for breast cancer in the elderly. Marchei P; Bianco V; Pignatelli E; Chiodini S; Santini D; Carico E; Marchei M; Vecchione A Anticancer Res; 1996; 16(2):911-3. PubMed ID: 8687150 [TBL] [Abstract][Full Text] [Related]
40. Leiomyoma of the breast in a 50-year-old woman receiving tamoxifen. Son EJ; Oh KK; Kim EK; Son HJ; Jung WH; Lee HD AJR Am J Roentgenol; 1998 Dec; 171(6):1684-6. PubMed ID: 9843313 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]